ITD Cementation India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 4, 2025, 10:34 am

Quick Insight

ITD Cementation India Ltd, currently priced at ₹771 with a market capitalization of ₹13,244 crore, exhibits strong financial health, evidenced by a P/E ratio of 36.6 and impressive return metrics—ROE at 21.8% and ROCE at 27.6%. The company maintains a healthy operational margin of 10% and a solid interest coverage ratio (ICR) of 3.64, indicating its ability to manage debt, which stands at ₹961 crore against reserves of ₹1,816 crore. With a negative cash conversion cycle of -63 days, ITD Cementation demonstrates effective working capital management. Given the robust promoter holding of 46.64% and a diverse shareholder base, the stock presents a compelling investment opportunity, suggesting potential for growth in the construction industry.

Competitors of ITD Cementation India Ltd

All Competitor Stocks of ITD Cementation India Ltd

Quarterly Result

Last Updated: August 1, 2025, 7:05 pm

Below is a detailed analysis of the quarterly data for ITD Cementation India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 2,542.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,480.00 Cr. (Mar 2025) to 2,542.00 Cr., marking an increase of 62.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,310.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,221.00 Cr. (Mar 2025) to 2,310.00 Cr., marking an increase of 89.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 233.00 Cr.. The value appears to be declining and may need further review. It has decreased from 258.00 Cr. (Mar 2025) to 233.00 Cr., marking a decrease of 25.00 Cr..
• For OPM %, as of Jun 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Mar 2025) to 9.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 22.00 Cr., marking an increase of 12.00 Cr..
• For Interest, as of Jun 2025, the value is 50.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 62.00 Cr. (Mar 2025) to 50.00 Cr., marking a decrease of 12.00 Cr..
• For Depreciation, as of Jun 2025, the value is 41.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 51.00 Cr. (Mar 2025) to 41.00 Cr., marking a decrease of 10.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 164.00 Cr.. The value appears strong and on an upward trend. It has increased from 155.00 Cr. (Mar 2025) to 164.00 Cr., marking an increase of 9.00 Cr..
• For Tax %, as of Jun 2025, the value is 16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 16.00%, marking a decrease of 11.00%.
• For Net Profit, as of Jun 2025, the value is 137.00 Cr.. The value appears strong and on an upward trend. It has increased from 114.00 Cr. (Mar 2025) to 137.00 Cr., marking an increase of 23.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 7.99. The value appears strong and on an upward trend. It has increased from 6.61 (Mar 2025) to 7.99, marking an increase of 1.38.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 6:17 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:55 am

Below is a detailed analysis of the balance sheet data for ITD Cementation India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 17.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,816.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,477.00 Cr. (Mar 2024) to 1,816.00 Cr., marking an increase of 339.00 Cr..
• For Borrowings, as of Mar 2025, the value is 961.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 889.00 Cr. (Mar 2024) to 961.00 Cr., marking an increase of 72.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 3,710.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,534.00 Cr. (Mar 2024) to 3,710.00 Cr., marking an increase of 176.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 6,505.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,917.00 Cr. (Mar 2024) to 6,505.00 Cr., marking an increase of 588.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,074.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,081.00 Cr. (Mar 2024) to 1,074.00 Cr., marking a decrease of 7.00 Cr..
• For CWIP, as of Mar 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 21.00 Cr., marking an increase of 11.00 Cr..
• For Investments, as of Mar 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2024) to 42.00 Cr., marking an increase of 37.00 Cr..
• For Other Assets, as of Mar 2025, the value is 5,367.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,821.00 Cr. (Mar 2024) to 5,367.00 Cr., marking an increase of 546.00 Cr..
• For Total Assets, as of Mar 2025, the value is 6,505.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,917.00 Cr. (Mar 2024) to 6,505.00 Cr., marking an increase of 588.00 Cr..

Notably, the Reserves (1,816.00 Cr.) exceed the Borrowings (961.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for ITD Cementation India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 15.93. This value is within the healthy range. It has increased from 7.23 (Mar 23) to 15.93, marking an increase of 8.70.
• For Diluted EPS (Rs.), as of Mar 24, the value is 15.93. This value is within the healthy range. It has increased from 7.23 (Mar 23) to 15.93, marking an increase of 8.70.
• For Cash EPS (Rs.), as of Mar 24, the value is 27.14. This value is within the healthy range. It has increased from 11.87 (Mar 23) to 27.14, marking an increase of 15.27.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 87.21. It has increased from 72.27 (Mar 23) to 87.21, marking an increase of 14.94.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 87.21. It has increased from 72.27 (Mar 23) to 87.21, marking an increase of 14.94.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 449.27. It has increased from 296.35 (Mar 23) to 449.27, marking an increase of 152.92.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 46.17. This value is within the healthy range. It has increased from 24.94 (Mar 23) to 46.17, marking an increase of 21.23.
• For PBIT / Share (Rs.), as of Mar 24, the value is 34.07. This value is within the healthy range. It has increased from 18.34 (Mar 23) to 34.07, marking an increase of 15.73.
• For PBT / Share (Rs.), as of Mar 24, the value is 21.38. This value is within the healthy range. It has increased from 8.71 (Mar 23) to 21.38, marking an increase of 12.67.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 15.04. This value is within the healthy range. It has increased from 5.27 (Mar 23) to 15.04, marking an increase of 9.77.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 15.93. This value is within the healthy range. It has increased from 7.23 (Mar 23) to 15.93, marking an increase of 8.70.
• For PBDIT Margin (%), as of Mar 24, the value is 10.27. This value is within the healthy range. It has increased from 8.41 (Mar 23) to 10.27, marking an increase of 1.86.
• For PBIT Margin (%), as of Mar 24, the value is 7.58. This value is below the healthy minimum of 10. It has increased from 6.18 (Mar 23) to 7.58, marking an increase of 1.40.
• For PBT Margin (%), as of Mar 24, the value is 4.75. This value is below the healthy minimum of 10. It has increased from 2.93 (Mar 23) to 4.75, marking an increase of 1.82.
• For Net Profit Margin (%), as of Mar 24, the value is 3.34. This value is below the healthy minimum of 5. It has increased from 1.77 (Mar 23) to 3.34, marking an increase of 1.57.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 3.54. This value is below the healthy minimum of 8. It has increased from 2.44 (Mar 23) to 3.54, marking an increase of 1.10.
• For Return on Networth / Equity (%), as of Mar 24, the value is 18.32. This value is within the healthy range. It has increased from 10.03 (Mar 23) to 18.32, marking an increase of 8.29.
• For Return on Capital Employeed (%), as of Mar 24, the value is 34.33. This value is within the healthy range. It has increased from 21.30 (Mar 23) to 34.33, marking an increase of 13.03.
• For Return On Assets (%), as of Mar 24, the value is 4.62. This value is below the healthy minimum of 5. It has increased from 2.47 (Mar 23) to 4.62, marking an increase of 2.15.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.13 (Mar 23) to 0.08, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.57. This value is within the healthy range. It has decreased from 0.58 (Mar 23) to 0.57, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.41. It has increased from 1.18 (Mar 23) to 1.41, marking an increase of 0.23.
• For Current Ratio (X), as of Mar 24, the value is 1.08. This value is below the healthy minimum of 1.5. It has increased from 1.04 (Mar 23) to 1.08, marking an increase of 0.04.
• For Quick Ratio (X), as of Mar 24, the value is 0.91. This value is below the healthy minimum of 1. It has increased from 0.87 (Mar 23) to 0.91, marking an increase of 0.04.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 4.70. This value is below the healthy minimum of 20. It has decreased from 6.22 (Mar 23) to 4.70, marking a decrease of 1.52.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 2.67. This value is below the healthy minimum of 20. It has decreased from 3.25 (Mar 23) to 2.67, marking a decrease of 0.58.
• For Earning Retention Ratio (%), as of Mar 24, the value is 95.30. This value exceeds the healthy maximum of 70. It has increased from 93.78 (Mar 23) to 95.30, marking an increase of 1.52.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 97.33. This value exceeds the healthy maximum of 70. It has increased from 96.75 (Mar 23) to 97.33, marking an increase of 0.58.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 3.64. This value is within the healthy range. It has increased from 2.59 (Mar 23) to 3.64, marking an increase of 1.05.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.19. This value is below the healthy minimum of 3. It has increased from 1.55 (Mar 23) to 2.19, marking an increase of 0.64.
• For Enterprise Value (Cr.), as of Mar 24, the value is 5,711.90. It has increased from 1,896.90 (Mar 23) to 5,711.90, marking an increase of 3,815.00.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.74. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 23) to 0.74, marking an increase of 0.37.
• For EV / EBITDA (X), as of Mar 24, the value is 7.20. This value is within the healthy range. It has increased from 4.43 (Mar 23) to 7.20, marking an increase of 2.77.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.74. This value is below the healthy minimum of 1. It has increased from 0.35 (Mar 23) to 0.74, marking an increase of 0.39.
• For Retention Ratios (%), as of Mar 24, the value is 95.29. This value exceeds the healthy maximum of 70. It has increased from 93.77 (Mar 23) to 95.29, marking an increase of 1.52.
• For Price / BV (X), as of Mar 24, the value is 3.84. This value exceeds the healthy maximum of 3. It has increased from 1.45 (Mar 23) to 3.84, marking an increase of 2.39.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.74. This value is below the healthy minimum of 1. It has increased from 0.35 (Mar 23) to 0.74, marking an increase of 0.39.
• For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 23) to 0.04, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness